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Summary
Tissue oxygenation response to adenosine stress in
patients with hypertrophic cardiomyopathy (HCM) is
blunted compared to athletes and normals. Myocardial
tissue hypoxia during stress in HCM may potentially
contribute to the increased exercise related deaths in
this condition.
Background
By exploiting the paramagnetic properties of deoxyhe-
moglobin, blood oxygen level-dependent (BOLD) MRI
can detect myocardial ischemia in patients with coron-
ary artery disease. However, little is known about myo-
cardial tissue oxygenation in pathological left ventricular
hypertrophy (e.g. HCM) or physiological hypertrophy (e.
g. elite athletes). Perfusion studies have shown that
patients with HCM show evidence of microvascular dys-
function, however, whether this leads to de-oxygenation
and ischemia is unclear.
Methods
Sixty nine age and gender matched subjects (26 HCM;
11 HCM gene carriers without hypertrophy; 12 athletes;
20 normal controls, )were studied at 3 Tesla (Siemens
Tim Trio), with acquisition of BOLD (using aT2-pre-
pared sequence) and first-pass perfusion images (using a
saturation recovery fast-gradient echo sequence and 0.03
mmol/kg Gd-DTPA bolus) at stress and rest (4-6 min-
utes i.v. adenosine, 140μg/kg/min). Signal intensity
change (SIΔ) and myocardial perfusion reserve index
(MPRI) were measured from BOLD and perfusion
images, respectively.
Results
During stress there were equivalent rises in rate pressure
product in all groups, (normal 73±20%, HCM 74±50%,
athlete 80±38%, P=NS).
There was a significantly reduced BOLD SIΔ response
in both HCM gene carriers and HCM (BOLD SIΔ:1 0
±11% gene carriers; 8±10% HCM P<0.0001 vs normal,
figure 1) compared to athletes (17±10%) and normal
volunteers (18±14% P=0.8). MPRI was also significantly
reduced in HCM, (normal controls: 1.8±0.6; athletes: 2.0
±0.9, P=0.005; HCM gene carriers: 1.6±0.7 P=0.001;
HCM: 1.3 ± 0.6 P<0.0001, figure 2). There was a weak
but significant correlation between BOLD SIΔ and
MPRI per segment, (R=0.27, P<0.0001) and between
BOLD SIΔ and end diastolic wall thickness per segment,
(R= 0.24, P< 0.001). Linear regression analysis showed
that both MPRI (b 0.2, P<0.001) and wall thickness (b-
0.2, P<0.001) are independent predictors of BOLD SIΔ.
Conclusions
Patients with HCM as well as HCM gene carriers with-
out evidence of hypertrophy show blunted myocardial
oxygenation response to vasodilator stress compared to 1Deprtment of Cardiovascular Medicine, University of Oxford, Oxford, UK
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any medium, provided the original work is properly cited.Figure 1 The mean and standard deviation of BOLD SIΔ% with adenosine stress in normal, athletes, and HCM patients with and without
hypertrophy. Error pars: standard error. * P<0.001 compared to normal; †P<0.001 compared to athletes.
Figure 2 The mean and standard deviation of MPRI with adenosine stress in normal, athlete, HCM with and without hypertrophy. Error pars:
standard error. * P<0.001 compared to normal; †P<0.001 compared to athletes; g P<0.05 compared to HCM with no hypertrophy.
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and thus oxygen demand, of contraction in HCM,
regardless of the degree of phenotype expression,
together with barriers to oxygen supply due to the
impaired perfusion are the most likely pathophysiologi-
cal mechanisms of de-oxygenation in these patients.
Importantly, myocardial tissue hypoxia may play a sig-
nificant pathophysiological role being potentially respon-
sible for stress-induced arrhythmia and sudden death in
HCM.
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